SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Antonio J. Blanca, María V. Ruiz-Armenta, Sonia Zambrano, José L. Miguel-Carrasco, José L. Arias, Miguel Arévalo, Alfonso Mate, Oscar Aramburu, Carmen M. Vázquez, Inflammatory and fibrotic processes are involved in the cardiotoxic effect of sunitinib: Protective role of l-carnitine, Toxicology Letters, 2016, 241, 9

    CrossRef

  2. 2
    Llilians Calvo Gonzalez, Sabrina Ghadaouia, Aurélie Martinez, Francis Rodier, Premature aging/senescence in cancer cells facing therapy: good or bad?, Biogerontology, 2016, 17, 1, 71

    CrossRef

  3. 3
    Karra A. Jones, Andrew S. Gilder, Michael S. Lam, Na Du, Michael A. Banki, Aran Merati, Donald P. Pizzo, Scott R. VandenBerg, Steven L. Gonias, Selective coexpression of VEGF receptor 2 in EGFRvIII-positive glioblastoma cells prevents cellular senescence and contributes to their aggressive nature, Neuro-Oncology, 2016, 18, 5, 667

    CrossRef

  4. 4
    Amaia Lujambio, To clear, or not to clear (senescent cells)? That is the question, Inside the Cell, 2016, 1, 2
  5. 5
    Esther A. Kleibeuker, Matthijs A. ten Hooven, Henk M. Verheul, Ben J. Slotman, Victor L. Thijssen, Combining radiotherapy with sunitinib: lessons (to be) learned, Angiogenesis, 2015, 18, 4, 385

    CrossRef

  6. 6
    Kevin P. Horn, Jeffrey T. Yap, Neeraj Agarwal, Kathryn A. Morton, Dan J. Kadrmas, Britney Beardmore, Regan I. Butterfield, Kenneth Boucher, John M. Hoffman, FDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinoma, Cancer Imaging, 2015, 15, 1

    CrossRef

  7. 7
    Esther A. Kleibeuker, Matthijs A. Hooven, Kitty C. Castricum, Richard Honeywell, Arjan W. Griffioen, Henk M. Verheul, Ben J. Slotman, Victor L. Thijssen, Optimal treatment scheduling of ionizing radiation and sunitinib improves the antitumor activity and allows dose reduction, Cancer Medicine, 2015, 4, 7
  8. 8
    Y Zhu, H Liu, L Xu, H An, W Liu, Y Liu, Z Lin, J Xu, p21-activated kinase 1 determines stem-like phenotype and sunitinib resistance via NF-κB/IL-6 activation in renal cell carcinoma, Cell Death and Disease, 2015, 6, 2, e1637

    CrossRef

  9. 9
    Weisi Liu, Haiou Liu, Yidong Liu, Le Xu, Weijuan Zhang, Yu Zhu, Jiejie Xu, Jianxin Gu, Prognostic Significance of p21-activated Kinase 6 Expression in Patients with Clear Cell Renal Cell Carcinoma, Annals of Surgical Oncology, 2014, 21, S4, 575

    CrossRef

  10. 10
    Jin Rong Ow, Yong Hua Tan, Yu Jin, Avinash G. Bahirvani, Reshma Taneja, bHLH Transcription Factors in Development and Disease, 2014,

    CrossRef

  11. 11
    Fernanda Augusta de Lima Barbosa Guterres, Glaucia Regina Martinez, Maria Eliane Merlin Rocha, Sheila Maria Brochado Winnischofer, Simvastatin rises reactive oxygen species levels and induces senescence in human melanoma cells by activation of p53/p21 pathway, Experimental Cell Research, 2013, 319, 19, 2977

    CrossRef